Skip to Main Content
Qurgen Qurgen
Menu Button

Dec. 2023

Brand Icon
In December 2023, Suzhou Fuent Pharmaceutical Co., Ltd. (Qurgen’s China subsidiary) received another 50 million RMB investment.

Recent important events

Mar. 2026
Qurgen announced that a late-stage of ocular melanoma patient from the ongoing Qurgen clinical trial...
Learn More
Jan. 13, 2026
Dr. Chai Yan officially Joined Qurgen/Fuent (The Qurgen’s China subsidiary) as Senior Vice President of...
Learn More